PRICE T ROWE ASSOCIATES INC /MD/ - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 211 filers reported holding DENALI THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 4.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$59,662
-41.3%
2,891,950
-16.1%
0.01%
-35.7%
Q2 2023$101,672
+24.7%
3,445,312
-2.6%
0.01%
+16.7%
Q1 2023$81,511
-19.7%
3,537,778
-3.0%
0.01%
-25.0%
Q4 2022$101,475
-99.9%
3,648,888
+4.9%
0.02%
-5.9%
Q3 2022$106,752,000
-21.3%
3,478,368
-24.6%
0.02%0.0%
Q2 2022$135,678,000
-14.3%
4,610,177
-6.4%
0.02%
+6.2%
Q1 2022$158,387,000
-23.4%
4,923,425
+6.2%
0.02%
-15.8%
Q4 2021$206,740,000
-13.9%
4,635,433
-2.6%
0.02%
-17.4%
Q3 2021$240,039,000
-37.6%
4,757,965
-3.0%
0.02%
-36.1%
Q2 2021$384,627,000
+11.2%
4,903,452
-19.1%
0.04%
+2.9%
Q1 2021$345,928,000
-36.1%
6,058,279
-6.3%
0.04%
-37.5%
Q4 2020$541,494,000
+246.5%
6,464,826
+48.2%
0.06%
+211.1%
Q3 2020$156,254,000
+146.4%
4,360,975
+66.3%
0.02%
+125.0%
Q2 2020$63,404,000
+199.0%
2,622,162
+116.5%
0.01%
+166.7%
Q1 2020$21,205,000
+191.8%
1,211,039
+190.3%
0.00%
+200.0%
Q4 2019$7,267,000
+7.8%
417,156
-5.2%
0.00%0.0%
Q3 2019$6,744,000
-32.5%
440,197
-8.5%
0.00%0.0%
Q2 2019$9,988,000
-10.6%
481,140
-0.0%
0.00%
-50.0%
Q1 2019$11,177,000
+13.4%
481,342
+0.9%
0.00%0.0%
Q4 2018$9,860,000
-4.7%
477,242
+0.2%
0.00%0.0%
Q3 2018$10,350,000
+86.6%
476,067
+30.9%
0.00%
+100.0%
Q2 2018$5,548,000
-24.2%
363,825
-2.1%
0.00%0.0%
Q1 2018$7,321,000371,8060.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Crestline Management, LP 7,705,039$343,645,00025.68%
Casdin Capital, LLC 1,500,000$66,900,0001.89%
Flagship Pioneering Inc. 2,619,968$116,851,0001.81%
SECTORAL ASSET MANAGEMENT INC 189,600$8,456,0001.27%
Integral Health Asset Management, LLC 100,000$4,460,0001.23%
Temasek Holdings (Private) Ltd 5,369,487$239,479,0000.86%
Goldstream Capital Management Ltd 78,418$3,497,0000.86%
Yiheng Capital Management, L.P. 335,184$14,949,0000.76%
GILDER GAGNON HOWE & CO LLC 2,900,114$129,345,0000.74%
Artal Group S.A. 600,000$26,760,0000.73%
View complete list of DENALI THERAPEUTICS INC shareholders